 | • レポートコード：QFJ1-5616 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、胆管がん用治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（医薬品、手術、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・胆管がん用治療薬の市場動向 ・企業の競争状況、市場シェア ・胆管がん用治療薬の種類別市場規模と予測2016-2027（医薬品、手術、その他） ・胆管がん用治療薬の用途別市場規模と予測2016-2027（病院、診療所、その他） ・胆管がん用治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・胆管がん用治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・胆管がん用治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・胆管がん用治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・胆管がん用治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、F. Hoffmann-La Roche、Bristol-Myers Squibb、Teva Pharmaceutical、Eli Lilly and Company、Sanofi、Fresenius Kabi、Mylan、Delcath Systems、Accord Healthcare、Intercept Pharmaceuticals、Celgene） ・結論 |
Bile Duct Cancer is a rare type of cancer that mainly affects adults aged over 65. Bile ducts are small tubes that connect the liver and small intestine that allow fluid called bile to flow from the liver, through the pancreas, to the gut, where it helps with digestion.
Market Analysis and Insights: Global Bile Duct Cancer Therapeutics Market
The global Bile Duct Cancer Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Bile Duct Cancer Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Bile Duct Cancer Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Bile Duct Cancer Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Bile Duct Cancer Therapeutics market.
Global Bile Duct Cancer Therapeutics Scope and Market Size
Bile Duct Cancer Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bile Duct Cancer Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Mecine
Surgery
Other
Segment by Application
Hospitals
Clinics
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Pfizer
F. Hoffmann-La Roche
Bristol-Myers Squibb
Teva Pharmaceutical
Eli Lilly and Company
Sanofi
Fresenius Kabi
Mylan
Delcath Systems
Accord Healthcare
Intercept Pharmaceuticals
Celgene
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bile Duct Cancer Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Mecine
1.2.3 Surgery
1.2.4 Other
1.3 Market by Application
1.3.1 Global Bile Duct Cancer Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Bile Duct Cancer Therapeutics Market Perspective (2016-2027)
2.2 Bile Duct Cancer Therapeutics Growth Trends by Regions
2.2.1 Bile Duct Cancer Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Bile Duct Cancer Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Bile Duct Cancer Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Bile Duct Cancer Therapeutics Industry Dynamic
2.3.1 Bile Duct Cancer Therapeutics Market Trends
2.3.2 Bile Duct Cancer Therapeutics Market Drivers
2.3.3 Bile Duct Cancer Therapeutics Market Challenges
2.3.4 Bile Duct Cancer Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bile Duct Cancer Therapeutics Players by Revenue
3.1.1 Global Top Bile Duct Cancer Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Bile Duct Cancer Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Bile Duct Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Bile Duct Cancer Therapeutics Revenue
3.4 Global Bile Duct Cancer Therapeutics Market Concentration Ratio
3.4.1 Global Bile Duct Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bile Duct Cancer Therapeutics Revenue in 2020
3.5 Bile Duct Cancer Therapeutics Key Players Head office and Area Served
3.6 Key Players Bile Duct Cancer Therapeutics Product Solution and Service
3.7 Date of Enter into Bile Duct Cancer Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Bile Duct Cancer Therapeutics Breakdown Data by Type
4.1 Global Bile Duct Cancer Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Bile Duct Cancer Therapeutics Forecasted Market Size by Type (2022-2027)
5 Bile Duct Cancer Therapeutics Breakdown Data by Application
5.1 Global Bile Duct Cancer Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Bile Duct Cancer Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Bile Duct Cancer Therapeutics Market Size (2016-2027)
6.2 North America Bile Duct Cancer Therapeutics Market Size by Type
6.2.1 North America Bile Duct Cancer Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Bile Duct Cancer Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Bile Duct Cancer Therapeutics Market Size by Type (2016-2027)
6.3 North America Bile Duct Cancer Therapeutics Market Size by Application
6.3.1 North America Bile Duct Cancer Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Bile Duct Cancer Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Bile Duct Cancer Therapeutics Market Size by Application (2016-2027)
6.4 North America Bile Duct Cancer Therapeutics Market Size by Country
6.4.1 North America Bile Duct Cancer Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Bile Duct Cancer Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Bile Duct Cancer Therapeutics Market Size (2016-2027)
7.2 Europe Bile Duct Cancer Therapeutics Market Size by Type
7.2.1 Europe Bile Duct Cancer Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Bile Duct Cancer Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Bile Duct Cancer Therapeutics Market Size by Type (2016-2027)
7.3 Europe Bile Duct Cancer Therapeutics Market Size by Application
7.3.1 Europe Bile Duct Cancer Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Bile Duct Cancer Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Bile Duct Cancer Therapeutics Market Size by Application (2016-2027)
7.4 Europe Bile Duct Cancer Therapeutics Market Size by Country
7.4.1 Europe Bile Duct Cancer Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Bile Duct Cancer Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Bile Duct Cancer Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Bile Duct Cancer Therapeutics Market Size by Type
8.2.1 Asia-Pacific Bile Duct Cancer Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Bile Duct Cancer Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Bile Duct Cancer Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Bile Duct Cancer Therapeutics Market Size by Application
8.3.1 Asia-Pacific Bile Duct Cancer Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Bile Duct Cancer Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Bile Duct Cancer Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Bile Duct Cancer Therapeutics Market Size by Region
8.4.1 Asia-Pacific Bile Duct Cancer Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Bile Duct Cancer Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Bile Duct Cancer Therapeutics Market Size (2016-2027)
9.2 Latin America Bile Duct Cancer Therapeutics Market Size by Type
9.2.1 Latin America Bile Duct Cancer Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Bile Duct Cancer Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Bile Duct Cancer Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Bile Duct Cancer Therapeutics Market Size by Application
9.3.1 Latin America Bile Duct Cancer Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Bile Duct Cancer Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Bile Duct Cancer Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Bile Duct Cancer Therapeutics Market Size by Country
9.4.1 Latin America Bile Duct Cancer Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Bile Duct Cancer Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bile Duct Cancer Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Bile Duct Cancer Therapeutics Market Size by Type
10.2.1 Middle East & Africa Bile Duct Cancer Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Bile Duct Cancer Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Bile Duct Cancer Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Bile Duct Cancer Therapeutics Market Size by Application
10.3.1 Middle East & Africa Bile Duct Cancer Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Bile Duct Cancer Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Bile Duct Cancer Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Bile Duct Cancer Therapeutics Market Size by Country
10.4.1 Middle East & Africa Bile Duct Cancer Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Bile Duct Cancer Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Bile Duct Cancer Therapeutics Introduction
11.1.4 Pfizer Revenue in Bile Duct Cancer Therapeutics Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Details
11.2.2 F. Hoffmann-La Roche Business Overview
11.2.3 F. Hoffmann-La Roche Bile Duct Cancer Therapeutics Introduction
11.2.4 F. Hoffmann-La Roche Revenue in Bile Duct Cancer Therapeutics Business (2016-2021)
11.2.5 F. Hoffmann-La Roche Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Bile Duct Cancer Therapeutics Introduction
11.3.4 Bristol-Myers Squibb Revenue in Bile Duct Cancer Therapeutics Business (2016-2021)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 Teva Pharmaceutical
11.4.1 Teva Pharmaceutical Company Details
11.4.2 Teva Pharmaceutical Business Overview
11.4.3 Teva Pharmaceutical Bile Duct Cancer Therapeutics Introduction
11.4.4 Teva Pharmaceutical Revenue in Bile Duct Cancer Therapeutics Business (2016-2021)
11.4.5 Teva Pharmaceutical Recent Development
11.5 Eli Lilly and Company
11.5.1 Eli Lilly and Company Company Details
11.5.2 Eli Lilly and Company Business Overview
11.5.3 Eli Lilly and Company Bile Duct Cancer Therapeutics Introduction
11.5.4 Eli Lilly and Company Revenue in Bile Duct Cancer Therapeutics Business (2016-2021)
11.5.5 Eli Lilly and Company Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Details
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Bile Duct Cancer Therapeutics Introduction
11.6.4 Sanofi Revenue in Bile Duct Cancer Therapeutics Business (2016-2021)
11.6.5 Sanofi Recent Development
11.7 Fresenius Kabi
11.7.1 Fresenius Kabi Company Details
11.7.2 Fresenius Kabi Business Overview
11.7.3 Fresenius Kabi Bile Duct Cancer Therapeutics Introduction
11.7.4 Fresenius Kabi Revenue in Bile Duct Cancer Therapeutics Business (2016-2021)
11.7.5 Fresenius Kabi Recent Development
11.8 Mylan
11.8.1 Mylan Company Details
11.8.2 Mylan Business Overview
11.8.3 Mylan Bile Duct Cancer Therapeutics Introduction
11.8.4 Mylan Revenue in Bile Duct Cancer Therapeutics Business (2016-2021)
11.8.5 Mylan Recent Development
11.9 Delcath Systems
11.9.1 Delcath Systems Company Details
11.9.2 Delcath Systems Business Overview
11.9.3 Delcath Systems Bile Duct Cancer Therapeutics Introduction
11.9.4 Delcath Systems Revenue in Bile Duct Cancer Therapeutics Business (2016-2021)
11.9.5 Delcath Systems Recent Development
11.10 Accord Healthcare
11.10.1 Accord Healthcare Company Details
11.10.2 Accord Healthcare Business Overview
11.10.3 Accord Healthcare Bile Duct Cancer Therapeutics Introduction
11.10.4 Accord Healthcare Revenue in Bile Duct Cancer Therapeutics Business (2016-2021)
11.10.5 Accord Healthcare Recent Development
11.11 Intercept Pharmaceuticals
11.11.1 Intercept Pharmaceuticals Company Details
11.11.2 Intercept Pharmaceuticals Business Overview
11.11.3 Intercept Pharmaceuticals Bile Duct Cancer Therapeutics Introduction
11.11.4 Intercept Pharmaceuticals Revenue in Bile Duct Cancer Therapeutics Business (2016-2021)
11.11.5 Intercept Pharmaceuticals Recent Development
11.12 Celgene
11.12.1 Celgene Company Details
11.12.2 Celgene Business Overview
11.12.3 Celgene Bile Duct Cancer Therapeutics Introduction
11.12.4 Celgene Revenue in Bile Duct Cancer Therapeutics Business (2016-2021)
11.12.5 Celgene Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Bile Duct Cancer Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Mecine
Table 3. Key Players of Surgery
Table 4. Key Players of Other
Table 5. Global Bile Duct Cancer Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Bile Duct Cancer Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Bile Duct Cancer Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Bile Duct Cancer Therapeutics Market Share by Regions (2016-2021)
Table 9. Global Bile Duct Cancer Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Bile Duct Cancer Therapeutics Market Share by Regions (2022-2027)
Table 11. Bile Duct Cancer Therapeutics Market Trends
Table 12. Bile Duct Cancer Therapeutics Market Drivers
Table 13. Bile Duct Cancer Therapeutics Market Challenges
Table 14. Bile Duct Cancer Therapeutics Market Restraints
Table 15. Global Bile Duct Cancer Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Bile Duct Cancer Therapeutics Market Share by Players (2016-2021)
Table 17. Global Top Bile Duct Cancer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bile Duct Cancer Therapeutics as of 2020)
Table 18. Ranking of Global Top Bile Duct Cancer Therapeutics Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Bile Duct Cancer Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Bile Duct Cancer Therapeutics Product Solution and Service
Table 22. Date of Enter into Bile Duct Cancer Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Bile Duct Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Bile Duct Cancer Therapeutics Revenue Market Share by Type (2016-2021)
Table 26. Global Bile Duct Cancer Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Bile Duct Cancer Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Bile Duct Cancer Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Bile Duct Cancer Therapeutics Revenue Market Share by Application (2016-2021)
Table 30. Global Bile Duct Cancer Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Bile Duct Cancer Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Bile Duct Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Bile Duct Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Bile Duct Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Bile Duct Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Bile Duct Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Bile Duct Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Bile Duct Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Bile Duct Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Bile Duct Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Bile Duct Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Bile Duct Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Bile Duct Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Bile Duct Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Bile Duct Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Bile Duct Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Bile Duct Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Bile Duct Cancer Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Bile Duct Cancer Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Bile Duct Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Bile Duct Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Bile Duct Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Bile Duct Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Bile Duct Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Bile Duct Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Bile Duct Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Bile Duct Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Bile Duct Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Bile Duct Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Bile Duct Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Bile Duct Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 62. Pfizer Company Details
Table 63. Pfizer Business Overview
Table 64. Pfizer Bile Duct Cancer Therapeutics Product
Table 65. Pfizer Revenue in Bile Duct Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 66. Pfizer Recent Development
Table 67. F. Hoffmann-La Roche Company Details
Table 68. F. Hoffmann-La Roche Business Overview
Table 69. F. Hoffmann-La Roche Bile Duct Cancer Therapeutics Product
Table 70. F. Hoffmann-La Roche Revenue in Bile Duct Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 71. F. Hoffmann-La Roche Recent Development
Table 72. Bristol-Myers Squibb Company Details
Table 73. Bristol-Myers Squibb Business Overview
Table 74. Bristol-Myers Squibb Bile Duct Cancer Therapeutics Product
Table 75. Bristol-Myers Squibb Revenue in Bile Duct Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 76. Bristol-Myers Squibb Recent Development
Table 77. Teva Pharmaceutical Company Details
Table 78. Teva Pharmaceutical Business Overview
Table 79. Teva Pharmaceutical Bile Duct Cancer Therapeutics Product
Table 80. Teva Pharmaceutical Revenue in Bile Duct Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 81. Teva Pharmaceutical Recent Development
Table 82. Eli Lilly and Company Company Details
Table 83. Eli Lilly and Company Business Overview
Table 84. Eli Lilly and Company Bile Duct Cancer Therapeutics Product
Table 85. Eli Lilly and Company Revenue in Bile Duct Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 86. Eli Lilly and Company Recent Development
Table 87. Sanofi Company Details
Table 88. Sanofi Business Overview
Table 89. Sanofi Bile Duct Cancer Therapeutics Product
Table 90. Sanofi Revenue in Bile Duct Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 91. Sanofi Recent Development
Table 92. Fresenius Kabi Company Details
Table 93. Fresenius Kabi Business Overview
Table 94. Fresenius Kabi Bile Duct Cancer Therapeutics Product
Table 95. Fresenius Kabi Revenue in Bile Duct Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 96. Fresenius Kabi Recent Development
Table 97. Mylan Company Details
Table 98. Mylan Business Overview
Table 99. Mylan Revenue in Bile Duct Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 100. Mylan Recent Development
Table 101. Delcath Systems Company Details
Table 102. Delcath Systems Business Overview
Table 103. Delcath Systems Bile Duct Cancer Therapeutics Product
Table 104. Delcath Systems Revenue in Bile Duct Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 105. Delcath Systems Recent Development
Table 106. Accord Healthcare Company Details
Table 107. Accord Healthcare Business Overview
Table 108. Accord Healthcare Bile Duct Cancer Therapeutics Product
Table 109. Accord Healthcare Revenue in Bile Duct Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 110. Accord Healthcare Recent Development
Table 111. Intercept Pharmaceuticals Company Details
Table 112. Intercept Pharmaceuticals Business Overview
Table 113. Intercept Pharmaceuticals Bile Duct Cancer Therapeutics Product
Table 114. Intercept Pharmaceuticals Revenue in Bile Duct Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 115. Intercept Pharmaceuticals Recent Development
Table 116. Celgene Company Details
Table 117. Celgene Business Overview
Table 118. Celgene Bile Duct Cancer Therapeutics Product
Table 119. Celgene Revenue in Bile Duct Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 120. Celgene Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bile Duct Cancer Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Mecine Features
Figure 3. Surgery Features
Figure 4. Other Features
Figure 5. Global Bile Duct Cancer Therapeutics Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Other Case Studies
Figure 9. Bile Duct Cancer Therapeutics Report Years Considered
Figure 10. Global Bile Duct Cancer Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Bile Duct Cancer Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Bile Duct Cancer Therapeutics Market Share by Regions: 2020 VS 2027
Figure 13. Global Bile Duct Cancer Therapeutics Market Share by Regions (2022-2027)
Figure 14. Global Bile Duct Cancer Therapeutics Market Share by Players in 2020
Figure 15. Global Top Bile Duct Cancer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bile Duct Cancer Therapeutics as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Bile Duct Cancer Therapeutics Revenue in 2020
Figure 17. Global Bile Duct Cancer Therapeutics Revenue Market Share by Type (2016-2021)
Figure 18. Global Bile Duct Cancer Therapeutics Revenue Market Share by Type (2022-2027)
Figure 19. North America Bile Duct Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Bile Duct Cancer Therapeutics Market Share by Type (2016-2027)
Figure 21. North America Bile Duct Cancer Therapeutics Market Share by Application (2016-2027)
Figure 22. North America Bile Duct Cancer Therapeutics Market Share by Country (2016-2027)
Figure 23. United States Bile Duct Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Bile Duct Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Bile Duct Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Bile Duct Cancer Therapeutics Market Share by Type (2016-2027)
Figure 27. Europe Bile Duct Cancer Therapeutics Market Share by Application (2016-2027)
Figure 28. Europe Bile Duct Cancer Therapeutics Market Share by Country (2016-2027)
Figure 29. Germany Bile Duct Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Bile Duct Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Bile Duct Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Bile Duct Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Bile Duct Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Bile Duct Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Bile Duct Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Bile Duct Cancer Therapeutics Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Bile Duct Cancer Therapeutics Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Bile Duct Cancer Therapeutics Market Share by Region (2016-2027)
Figure 39. China Bile Duct Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Bile Duct Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Bile Duct Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Bile Duct Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Bile Duct Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Bile Duct Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Bile Duct Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Bile Duct Cancer Therapeutics Market Share by Type (2016-2027)
Figure 47. Latin America Bile Duct Cancer Therapeutics Market Share by Application (2016-2027)
Figure 48. Latin America Bile Duct Cancer Therapeutics Market Share by Country (2016-2027)
Figure 49. Mexico Bile Duct Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Bile Duct Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Bile Duct Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Bile Duct Cancer Therapeutics Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Bile Duct Cancer Therapeutics Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Bile Duct Cancer Therapeutics Market Share by Country (2016-2027)
Figure 55. Turkey Bile Duct Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Bile Duct Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Bile Duct Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Pfizer Revenue Growth Rate in Bile Duct Cancer Therapeutics Business (2016-2021)
Figure 59. F. Hoffmann-La Roche Revenue Growth Rate in Bile Duct Cancer Therapeutics Business (2016-2021)
Figure 60. Bristol-Myers Squibb Revenue Growth Rate in Bile Duct Cancer Therapeutics Business (2016-2021)
Figure 61. Teva Pharmaceutical Revenue Growth Rate in Bile Duct Cancer Therapeutics Business (2016-2021)
Figure 62. Eli Lilly and Company Revenue Growth Rate in Bile Duct Cancer Therapeutics Business (2016-2021)
Figure 63. Sanofi Revenue Growth Rate in Bile Duct Cancer Therapeutics Business (2016-2021)
Figure 64. Fresenius Kabi Revenue Growth Rate in Bile Duct Cancer Therapeutics Business (2016-2021)
Figure 65. Mylan Revenue Growth Rate in Bile Duct Cancer Therapeutics Business (2016-2021)
Figure 66. Delcath Systems Revenue Growth Rate in Bile Duct Cancer Therapeutics Business (2016-2021)
Figure 67. Accord Healthcare Revenue Growth Rate in Bile Duct Cancer Therapeutics Business (2016-2021)
Figure 68. Intercept Pharmaceuticals Revenue Growth Rate in Bile Duct Cancer Therapeutics Business (2016-2021)
Figure 69. Celgene Revenue Growth Rate in Bile Duct Cancer Therapeutics Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
世界の胆管がん治療薬市場規模・現状・予測（2021年-2027年） Bile duct connects the liver to the gallbladder and carries bile, which is synthesized by the liver and stored in the gallbladder. The main function of bile is breakdown of fat during digestion. Bile duct cancer is commonly known as cholangiocarcinoma. The specific cause of bile duct cancer is unkno…- 世界の膵臓＆胆管がん治療薬市場規模・現状・予測（2021年-2027年） It is a drug for treating pancreatic cancer with bile duct cancer. Pancreatic cancer is a disease in which malignant (cancer) cells are found in pancreatic tissue. The pancreas is a large gland located in the abdominal cavity and is responsible for the secretion of digestive juice and insulin. Sympt…
- 胆管がん治療薬のグローバル市場調査 2019年 The global Bile Duct Cancer Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Bile Duct Cancer Drug volume and value at global level, regional level and company level. From a global perspective, …
- 世界の咽頭がん治療薬市場規模・現状・予測（2021年-2027年） Laryngeal cancer are mostly squamous cell carcinomas, reflecting their origin from the skin of the larynx.Oropharyngeal cancer is a disease in which cancer form in the tissues of the throat (oropharynx). There is an increase in the prevalence of throat cancer across the world despite advances in the…
- 世界の卵管がん治療薬市場規模・現状・予測（2021年-2027年） Fallopian tube cancer also called as tubal cancer is caused due to uncontrolled growth of cells in fallopian tubes that connect the ovaries and the uterus. Market Analysis and Insights: Global Fallopian Tube Cancer Therapeutics Market The global Fallopian Tube Cancer Therapeutics market size is pro…